Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction

NCT06800274 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Allergic Conjunctivitis
Dry Eye Disease (DED)

Interventions

DRUG: NAAGA (N-acetyl-aspartyl-glutamate) 49 mg/mL
DRUG: azelastine hydrochloride 0.05%

Sponsor

Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona